Related references
Note: Only part of the references are listed.481 LONG-TERM FOLLOW-UP RESULTS OF A RANDOMIZED TRIAL COMPARING RADIOFREQUENCY ABLATION VERSUS ENDOSCOPIC SURVEILLANCE IN BARRETT'S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA
Esther Klaver et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer
Mats Lindblad et al.
WORLD JOURNAL OF SURGERY (2017)
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia
Lucas C. Duits et al.
GASTROENTEROLOGY (2017)
Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis
Vincent T. Janmaat et al.
PLOS ONE (2017)
Predictors of Progression in Barrett's Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry
Rajesh Krishnamoorthi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus
Nicholas J. Shaheen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Personalized screening intervals for biomarkers using joint models for longitudinal and survival data
Dimitris Rizopoulos et al.
BIOSTATISTICS (2016)
Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa
Rita Barros et al.
DISEASE MARKERS (2016)
The R Package JMbayes for Fitting Joint Models for Longitudinal and Time-to-Event Data Using MCMC
Dimitris Rizopoulos
JOURNAL OF STATISTICAL SOFTWARE (2016)
SOX2 as a Novel Marker to Predict Neoplastic Progression in Barrett's Esophagus
Sophie van Olphen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Paired exome analysis of Barrett's esophagus and adenocarcinoma
Matthew D. Stachler et al.
NATURE GENETICS (2015)
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
Rebecca C. Fitzgerald et al.
GUT (2014)
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial
K. Nadine Phoa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
Florine Kastelein et al.
GUT (2013)
Evaluation epidermal p53 immunostaining by digital image analysis
Gabrielli Brianezi et al.
SKIN RESEARCH AND TECHNOLOGY (2013)
A Clinical Risk Prediction Model for Barrett Esophagus
Aaron P. Thrift et al.
CANCER PREVENTION RESEARCH (2012)
American Gastroenterological Association Medical Position Statement on the Management of Barrett's Esophagus
Stuart J. Spechler et al.
GASTROENTEROLOGY (2011)
Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus
Sachin Wani et al.
GASTROENTEROLOGY (2011)
Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus
E Lörinc et al.
HISTOPATHOLOGY (2005)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer
A Fountoulakis et al.
BRITISH JOURNAL OF SURGERY (2004)
Barrett's esophagus can and does regress after antireflux surgery: A study of prevalence and predictive features
RR Gurski et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Superficial adenocarcinoma of the esophagus
TW Rice et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Share Paper
